Filing Details
- Accession Number:
- 0001104659-18-071882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-07 18:05:41
- Reporting Period:
- 2018-12-04
- Accepted Time:
- 2018-12-07 18:05:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1467652 | Neos Therapeutics Inc. | NEOS | Pharmaceutical Preparations (2834) | 270395455 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1495412 | W. Gerald Mclaughlin | C/O Neos Therapeutics, Inc. 2940 N. Hwy 360 Grand Prairie TX 75050 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-04 | 7,403 | $2.04 | 7,403 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide Neos Therapeutics, Inc., any security holder of Neos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
